Membranous nephropathy in the UK Biobank
PLOS ONE · 27.04.2023 · 18 (4) · e0281795
DOI: 10.1371/journal.pone.0281795 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 27.04.2023. Verfasst von Patrick Hamilton und 10 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Academic Health Science Centre (MAHSC), The University of Manchester, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Nephrotic Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK, Kidney Foundation of Canada.
Abstract (Originalsprache)
Background
Despite MN being one of the most common causes of nephrotic syndrome worldwide, its biological and environmental determinants are poorly understood in large-part due to it being a rare disease. Making use of the UK Biobank, a unique resource holding a clinical dataset and stored DNA, serum and urine for ~500,000 participants, this study aims to address this gap in understanding.
Methods
The primary outcome was putative MN as defined by ICD-10 codes occurring in the UK Biobank. Univariate relative risk regression modelling was used to assess the associations between the incidence of MN and related phenotypes with sociodemographic, environmental exposures, and previously described increased-risk SNPs.
Results
502,507 patients were included in the study of whom 100 were found to have a putative diagnosis of MN; 36 at baseline and 64 during the follow-up. Prevalence at baseline and last follow-up were 72 and 199 cases/million respectively. At baseline, as expected, the majority of those previously diagnosed with MN had proteinuria, and there was already evidence of proteinuria in patients diagnosed within the first 5 years of follow-up. The highest incidence rate for MN in patients was seen in those homozygous for the high-risk alleles (9.9/100,000 person-years).
Conclusion
It is feasible to putatively identify patients with MN in the UK Biobank and cases are still accumulating. This study shows the chronicity of disease with proteinuria present years before diagnosis. Genetics plays an important role in disease pathogenesis, with the at-risk group providing a potential population for recall.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Manchester Academic Health Science Centre (MAHSC), The University of Manchester, Manchester, United Kingdom.
- Faculty of Biology Medicine and Health, Division of Cell Matrix Biology and Regenerative Medicine, Wellcome Centre for Cell-Matrix Research, School of Biological Sciences, The University of Manchester, Manchester, Unite…
- Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, United Kingdom.
- Centre for Biostatistics, The University of Manchester, Manchester, United Kingdom.
- UCL Department of Renal Medicine, UCL Medical School, London, United Kingdom.
ORCID-Profile: Patrick Hamilton, Kieran Blaikie
Förderung
- Kidney Research UK
- Kidney Foundation of Canada
Zitieren
APA
Hamilton, P., Blaikie, K., Roberts, S. A., Gittins, M., Downie, M. L., Gupta, S., Voinescu, C., Kanigicherla, D., Stanescu, H., Kleta, R., & Brenchley, P. (2023). Membranous nephropathy in the UK Biobank. PLOS ONE, 18(4), e0281795. https://doi.org/10.1371/journal.pone.0281795
Vancouver
Hamilton P, Blaikie K, Roberts SA, Gittins M, Downie ML, Gupta S, et al. Membranous nephropathy in the UK Biobank. PLOS ONE. 2023;18(4):e0281795. doi:10.1371/journal.pone.0281795
BibTeX
@article{Hamilton2023,
author = {Hamilton, Patrick and Blaikie, Kieran and Roberts, Stephen A and Gittins, Matthew and Downie, Mallory L and Gupta, Sanjana and Voinescu, Catalin and Kanigicherla, Durga and Stanescu, Horia and Kleta, Robert and Brenchley, Paul},
title = {Membranous nephropathy in the UK Biobank},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {4},
pages = {e0281795},
doi = {10.1371/journal.pone.0281795}
}
EUVIMED